
Alert: Rating Upgrade (4/4/25)-Capricor Therapeutics Inc (NASDAQ: CAPR).
Stock Rating Upgrade The Value Trend Rating for Capricor Therapeutics Inc (NASDAQ: CAPR) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]